カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ゲムツズマブオゾガマイシンの世界市場見通し2023年-2029年

◆英語タイトル：Gemtuzumab Ozogamicin Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5582）

◆商品コード：MMG23JU5582
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Gemtuzumab Ozogamicin Drugs Market 調査レポートは次の情報を含め、グローバルにおけるのゲムツズマブオゾガマイシン市場規模と予測を収録しています。・世界のゲムツズマブオゾガマイシン市場：売上、2018年-2023年、2024年-2029年
・世界のゲムツズマブオゾガマイシン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のゲムツズマブオゾガマイシン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「5mg/バイアル」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ゲムツズマブオゾガマイシンのグローバル主要企業は、Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ゲムツズマブオゾガマイシンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のゲムツズマブオゾガマイシン市場：タイプ別、2018年-2023年、2024年-2029年
世界のゲムツズマブオゾガマイシン市場：タイプ別市場シェア、2022年
・5mg/バイアル、4.5mg/バイアル

世界のゲムツズマブオゾガマイシン市場：用途別、2018年-2023年、2024年-2029年
世界のゲムツズマブオゾガマイシン市場：用途別市場シェア、2022年
・病院、薬局

世界のゲムツズマブオゾガマイシン市場：地域・国別、2018年-2023年、2024年-2029年
世界のゲムツズマブオゾガマイシン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるゲムツズマブオゾガマイシンのグローバル売上、2018年-2023年
・主要企業におけるゲムツズマブオゾガマイシンのグローバル売上シェア、2022年
・主要企業におけるゲムツズマブオゾガマイシンのグローバル販売量、2018年-2023年
・主要企業におけるゲムツズマブオゾガマイシンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Pfizer

*************************************************************

・調査・分析レポートの概要
ゲムツズマブオゾガマイシン市場の定義
市場セグメント
世界のゲムツズマブオゾガマイシン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のゲムツズマブオゾガマイシン市場規模
世界のゲムツズマブオゾガマイシン市場規模：2022年 VS 2029年
世界のゲムツズマブオゾガマイシン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのゲムツズマブオゾガマイシンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のゲムツズマブオゾガマイシン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：5mg/バイアル、4.5mg/バイアル
ゲムツズマブオゾガマイシンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
ゲムツズマブオゾガマイシンの用途別グローバル売上・予測

・地域別市場分析
地域別ゲムツズマブオゾガマイシン市場規模 2022年と2029年
地域別ゲムツズマブオゾガマイシン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Pfizer
...

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
This report aims to provide a comprehensive presentation of the global market for Gemtuzumab Ozogamicin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemtuzumab Ozogamicin Drugs. This report contains market size and forecasts of Gemtuzumab Ozogamicin Drugs in global, including the following market information:
Global Gemtuzumab Ozogamicin Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gemtuzumab Ozogamicin Drugs Market Sales, 2018-2023, 2024-2029, (kUnits)
Global top five Gemtuzumab Ozogamicin Drugs companies in 2022 (%)
The global Gemtuzumab Ozogamicin Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
5mg/Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gemtuzumab Ozogamicin Drugs include Pfizer. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gemtuzumab Ozogamicin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gemtuzumab Ozogamicin Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, by Type, 2022 (%)
5mg/Vial
4.5mg/Vial
Global Gemtuzumab Ozogamicin Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Gemtuzumab Ozogamicin Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gemtuzumab Ozogamicin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gemtuzumab Ozogamicin Drugs revenues share in global market, 2022 (%)
Key companies Gemtuzumab Ozogamicin Drugs sales in global market, 2018-2023 (Estimated), (kUnits)
Key companies Gemtuzumab Ozogamicin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gemtuzumab Ozogamicin Drugs, market overview.
Chapter 2: Global Gemtuzumab Ozogamicin Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gemtuzumab Ozogamicin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gemtuzumab Ozogamicin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gemtuzumab Ozogamicin Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Gemtuzumab Ozogamicin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gemtuzumab Ozogamicin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gemtuzumab Ozogamicin Drugs Overall Market Size
2.1 Global Gemtuzumab Ozogamicin Drugs Market Size: 2022 VS 2029
2.2 Global Gemtuzumab Ozogamicin Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gemtuzumab Ozogamicin Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gemtuzumab Ozogamicin Drugs Players in Global Market
3.2 Top Global Gemtuzumab Ozogamicin Drugs Companies Ranked by Revenue
3.3 Global Gemtuzumab Ozogamicin Drugs Revenue by Companies
3.4 Global Gemtuzumab Ozogamicin Drugs Sales by Companies
3.5 Global Gemtuzumab Ozogamicin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gemtuzumab Ozogamicin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gemtuzumab Ozogamicin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gemtuzumab Ozogamicin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gemtuzumab Ozogamicin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gemtuzumab Ozogamicin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gemtuzumab Ozogamicin Drugs Market Size Markets, 2022 & 2029
4.1.2 5mg/Vial
4.1.3 4.5mg/Vial
4.2 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
4.2.1 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
4.2.2 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
4.2.3 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
4.3.1 By Type – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
4.3.2 By Type – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
4.3.3 By Type – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Gemtuzumab Ozogamicin Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gemtuzumab Ozogamicin Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
5.2.1 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
5.2.2 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
5.2.3 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
5.3.1 By Application – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
5.3.2 By Application – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
5.3.3 By Application – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Gemtuzumab Ozogamicin Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gemtuzumab Ozogamicin Drugs Market Size, 2022 & 2029
6.2 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
6.2.1 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
6.2.2 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
6.2.3 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
6.3.1 By Region – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
6.3.2 By Region – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
6.3.3 By Region – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.4.2 By Country – North America Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.4.3 US Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.4.4 Canada Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.4.5 Mexico Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.5.3 Germany Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.4 France Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.5 U.K. Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.6 Italy Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.7 Russia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.9 Benelux Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.6.3 China Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.4 Japan Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.5 South Korea Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.7 India Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.7.2 By Country – South America Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.7.3 Brazil Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.7.4 Argentina Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.8.3 Turkey Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.4 Israel Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.6 UAE Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gemtuzumab Ozogamicin Drugs Major Product Offerings
7.1.4 Pfizer Gemtuzumab Ozogamicin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
8 Global Gemtuzumab Ozogamicin Drugs Production Capacity, Analysis
8.1 Global Gemtuzumab Ozogamicin Drugs Production Capacity, 2018-2029
8.2 Gemtuzumab Ozogamicin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gemtuzumab Ozogamicin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gemtuzumab Ozogamicin Drugs Supply Chain Analysis
10.1 Gemtuzumab Ozogamicin Drugs Industry Value Chain
10.2 Gemtuzumab Ozogamicin Drugs Upstream Market
10.3 Gemtuzumab Ozogamicin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gemtuzumab Ozogamicin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Gemtuzumab Ozogamicin Drugs in Global Market
Table 2. Top Gemtuzumab Ozogamicin Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gemtuzumab Ozogamicin Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gemtuzumab Ozogamicin Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Gemtuzumab Ozogamicin Drugs Sales by Companies, (kUnits), 2018-2023
Table 6. Global Gemtuzumab Ozogamicin Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gemtuzumab Ozogamicin Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Gemtuzumab Ozogamicin Drugs Product Type
Table 9. List of Global Tier 1 Gemtuzumab Ozogamicin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gemtuzumab Ozogamicin Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2018-2023
Table 15. By Type - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2024-2029
Table 16. By Application – Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2018-2023
Table 20. By Application - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2024-2029
Table 21. By Region – Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gemtuzumab Ozogamicin Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2018-2023
Table 25. By Region - Global Gemtuzumab Ozogamicin Drugs Sales (kUnits), 2024-2029
Table 26. By Country - North America Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2018-2023
Table 29. By Country - North America Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2024-2029
Table 30. By Country - Europe Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2018-2023
Table 33. By Country - Europe Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2024-2029
Table 34. By Region - Asia Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2018-2023
Table 37. By Region - Asia Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2024-2029
Table 38. By Country - South America Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2018-2023
Table 41. By Country - South America Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2024-2029
Table 42. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2018-2023
Table 45. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales, (kUnits), 2024-2029
Table 46. Pfizer Company Summary
Table 47. Pfizer Gemtuzumab Ozogamicin Drugs Product Offerings
Table 48. Pfizer Gemtuzumab Ozogamicin Drugs Sales (kUnits), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Gemtuzumab Ozogamicin Drugs Production Capacity (kUnits) of Key Manufacturers in Global Market, 2021-2023 (kUnits)
Table 51. Global Gemtuzumab Ozogamicin Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Gemtuzumab Ozogamicin Drugs Production by Region, 2018-2023 (kUnits)
Table 53. Global Gemtuzumab Ozogamicin Drugs Production by Region, 2024-2029 (kUnits)
Table 54. Gemtuzumab Ozogamicin Drugs Market Opportunities & Trends in Global Market
Table 55. Gemtuzumab Ozogamicin Drugs Market Drivers in Global Market
Table 56. Gemtuzumab Ozogamicin Drugs Market Restraints in Global Market
Table 57. Gemtuzumab Ozogamicin Drugs Raw Materials
Table 58. Gemtuzumab Ozogamicin Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Gemtuzumab Ozogamicin Drugs Downstream
Table 60. Gemtuzumab Ozogamicin Drugs Downstream Clients in Global Market
Table 61. Gemtuzumab Ozogamicin Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gemtuzumab Ozogamicin Drugs Segment by Type in 2022
Figure 2. Gemtuzumab Ozogamicin Drugs Segment by Application in 2022
Figure 3. Global Gemtuzumab Ozogamicin Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gemtuzumab Ozogamicin Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Gemtuzumab Ozogamicin Drugs Sales in Global Market: 2018-2029 (kUnits)
Figure 8. The Top 3 and 5 Players Market Share by Gemtuzumab Ozogamicin Drugs Revenue in 2022
Figure 9. By Type - Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Gemtuzumab Ozogamicin Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Gemtuzumab Ozogamicin Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 23. US Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 28. Germany Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 37. China Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Gemtuzumab Ozogamicin Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Gemtuzumab Ozogamicin Drugs Production Capacity (kUnits), 2018-2029
Figure 53. The Percentage of Production Gemtuzumab Ozogamicin Drugs by Region, 2022 VS 2029
Figure 54. Gemtuzumab Ozogamicin Drugs Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ゲムツズマブオゾガマイシンの世界市場見通し2023年-2029年(Gemtuzumab Ozogamicin Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ゲムツズマブオゾガマイシンの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp